AbCellera’s menopause medicine ‘sets new efficacy bar’ for hot flashes

AbCellera Biologics’ reduction in hot flashes sets it apart from currently commercial oral drugs, including Astellas’ Veozah and Bayer’s Lynkuet, according to BMO Capital Markets.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top